Invasive fungal sinusitis can be classified as acute, chronic and chronic granulomatous, and tends to be encountered more in the immune-compromised population, particularly the acute form, which is rapidly progressive and may demonstrate bone erosion, vascular invasion and intracranial extension.
What does IFS stand for?
IFS stands for Invasive Fungal Sinusitis
This definition appears rarely and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of IFS
We have 267 other meanings of IFS in our Acronym Attic
- International Fleet Sales (various locations)
- International Food Standard
- International Forensic Sciences (India)
- International Foundation for Science
- International Freephone Service
- International Friendship Society
- Internet File System (Oracle)
- Interpretive Frame System (AT&T)
- Interstate Freight Systems (Ontario, Canada)
- Introductory Flight Screening (US Navy)
- Ionospheric Forward Scatter (ITS)
- IOS File System (Cisco Systems Inc.)
- Iranian Foundrymen's Society
- Islamic Financial Services (various locations)
- Islamic Foundation School (Villa Park, Illinois)
- Iterated Function System
- Itochu Fashion System Co., Ltd. (Japan)
- Inactive Facilities Surveillance And Maintenance
- Integrated Facilities System-Increment I
- Integrated Facilities System-Micro/Mini
Samples in periodicals archive:
In 1996, Gucalp et al reported a case of invasive fungal sinusitis in an immunocompromised patient with acute myeloid leukemia; the pathogen, which was identified as P lilacinus on culture, was resistant to amphotericin B, but the patient was effectively treated with itraconazole and surgery.
Invasive fungal sinusitis in patients undergoing bone marrow transplantation.
This results in therapeutic confusion, since invasive fungal sinusitis is a completely different clinicopathologic entity from AFS and requires far more aggressive therapy, including toxic antifungal agents such as Amphotericin B.
Whereas invasive fungal sinusitis is more common in immunocompromised patients, mycetomas are more often seen in immunocompetent patients.
Chronic invasive fungal sinusitis occurs in patients with little or no evidence of immunocompromise, and it tends to present more insidiously over weeks to months.
We describe a new case of invasive fungal sinusitis secondary to P boydii infection, and we review the literature on this emerging pathogen.
2) Traditionally, descriptions of the clinical presentations of fungal sinus disease have ranged from aggressive invasive fungal sinusitis in immunocompromised hosts to more indolent forms in immunocompetent patients.